To determine the prevalence of metabolic syndrome in the Japanese general population, we analyzed data from a nationwide survey conducted in 2000. According to the Japanese new diagnostic criteria for metabolic syndrome in 2005, we analyzed 3,264 people aged from 20 to 79 (men, 1,917; women, 1,347) from the total participants. The incidence of metabolic syndrome was 7.8%. Men had a higher incidence (12.1%) than women (1.7%). Most of the women satisfying the criteria were 50 years old or over, while the incidence in men started to rise from their 30s. When we applied the criteria of Adult Treatment Panel , the incidence was about 3-fold higher. In this population visceral obesity was associated with metabolic abnormalities, such as higher LDL-cholesterol, triglyceride, glucose, and blood pressure and lower HDL-cholesterol. Thus we determined the incidence of metabolic syndrome and each metabolic abnormality in the Japanese general population in 2000 and found an association of visceral obesity with metabolic abnormalities. Intervention to reduce the incidence of metabolic syndrome in Japan is necessary to reduce the risk of cardiovascular disease. 
Introduction
Metabolic syndrome is a constellation of multiple risk factors, such as dyslipidemia, elevated glucose, and elevated blood pressure. This syndrome has received increased attention due to its association with increased risk for cardiovascular disease and type 2 diabetes 1) . Although the pathogenesis of metabolic syn-drome has not been fully understood, the predominant underlying risk factor is considered to be visceral obesity due to an atherogenic diet and physical inactivity in the presence of some unknown genetic background [2] [3] [4] . In women the incidence of metabolic syndrome increases after menopause; therefore, hormonal imbalance and aging are also associated with the development of metabolic syndrome 5) . Along with the westernization of lifestyle, the incidence of metabolic disorders, such as dyslipidemia, hypertension, and diabetes is increasing in Japan. In spite of the availability of many drugs, such as statins, angiotensin-converting enzyme inhibitors, and aspirin, the incidence of cardiovascular disease is not decreasing in Japan, probably due to these metabolic abnormalities, especially dyslipidemia and diabetes along with obesity according to the national survey by the Ministry of Health, Labour and Welfare (http://www. mhlw.go.jp/toukei/saikin/hw/kenkou/jyunkan/ jyunkan00/gaiyo.html). In 2000, we conducted a lipid survey in various districts in Japan 6) . What we found in this survey was that the level of triglyceride increased in middle-aged men along with increased body mass index (BMI) compared with the data in 1990 7) . This increase in BMI also suggests an increase in the incidence of visceral obesity and metabolic syndrome; therefore, knowing the incidence of metabolic syndrome is very important from the standpoint of preventive medicine.
In the last few years, several expert groups have attempted to set forth simple diagnostic criteria to be used in clinical practice to identify patients with metabolic syndrome. The committee of International Diabetes Federation (IDF) adopted waist circumference as the surrogate marker for visceral obesity as an essential component of this syndrome (http://www.idf.org/ webdata/docs/IDF_Metasyndrome_definition.pdf ). In Japan the committee established diagnostic criteria under the same principle as that used in the IDF criteria, except that the cutoff point for high glucose is 110 mg/dL instead of 100 mg/dL 8) . The cutoff of waist circumference for visceral obesity was adopted as 85 cm in men and 90 cm in women. Meanwhile, the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP ) criteria required no single factor for diagnosis, but instead required the presence of at least 3 out of 5 components for diagnosis 9) ; thus, complete agreement on the definition and diagnostic criteria has not been achieved so far.
The purpose of this study is to examine the incidence of metabolic syndrome in the Japanese general population and the relationship with the risk factors included in the diagnostic criteria. We also compared the incidence of metabolic syndrome by using the NCEP-ATP new diagnostic criteria.
Methods

Design and Data Collection
The Research Group on Serum Lipid Level Survey 2000 in Japan organized the members of 36 institutes from various areas around Japan. The project was designed to produce representative data about serum lipid levels in the civilian Japanese population. The subjects were people receiving annual health examinations in the general community, companies, and schools, and not patient-visiting hospitals. Among the 12,839 participants we measured the waist circumference of 3,264 people aged 20 to 79 (men 1,917; women, 1,357) and examined the incidence of metabolic syndrome.
Laboratory Methods
All serum and plasma samples were obtained in the fasting state. All lipid and other analyses were conducted on venous blood samples within one week of collection at BML (Saitama, Japan). Serum cholesterol and triglyceride levels were measured by enzymatic assay. HDL-cholesterol and LDL-cholesterol were measured enzymatically using a kit from Daiichi Kagaku Co. Ltd. (Tokyo, Japan). The results of lipid analyses in the four surveys were indirectly standardized according to the criteria of the CDC Lipid Standardization Program 10) . Thus, the cholesterol levels in these five surveys appear comparable. Plasma glucose was determined enzymatically and HbA1c was determined using a kit from Kyowa Medex Co.Ltd (Tokyo, Japan). Serum insulin was determined by immunoradiometric assay (Abbott Diagnostics Division, Abbot Park, IL). Waist circumference at the umbilical level was measured in the late exhalation phase in a standing position.
Definition of Metabolic Syndrome
According to the new definition released by the Japanese Committee for the Diagnostic Criteria of Metabolic Syndrome in April 2005, we defined metabolic syndrome as the presence of 2 or more abnormalities in addition to visceral obesity (waist circumference: 85 cm or more in men, 90 cm or more in women). These three abnormalities are as follows: 1, triglycerides 150 mg/dL and/or HDL-cholesterol 40 mg/dL or under treatment for this type of dyslipidemia, 2, systolic blood pressure 130 and/or diastolic blood pressure 85, or under treatment for hypertension, 3, fasting glucose 110 mg/dL or under treatment for diabetes. People treated for dyslipid-emia were excluded, because we could not obtain data as to whether they were treated for hypercholesterolemia or hypertriglyceridemia. We also analyzed the incidence of metabolic syndrome by ATP criteria published in 2005 9) . We modified the criteria by using the Japanese cutoff of waist circumference. Other differences are fasting glucose 100 mg/dL and HDLcholesterol 50 mg/dL in women. Metabolic syndrome in ATP criteria was defined as the presence of at least 3 abnormalities among visceral obesity, hypertriglyceridemia, low HDL-cholesterolemia, hypertension, and glucose intolerance.
Data Analysis
The results are expressed as the mean value standard deviation, and categorical data by the incidence and relation between visceral obesity and various factors were expressed by the odds ratio and 95% confidence interval. Differences in the means were evaluated by analysis of variance (ANOVA) or analysis of covariance (ANCOVA). The relation between visceral obesity and various factors was examined using multiple, logistic regression analysis for multivariate analysis. Analysis was performed using the statistical Package for Social Sciences (SPSS Japan Inc. ver. 11.5, Tokyo, Japan). A p value of 0.05 or less was considered to indicate significant difference. Table 1 shows the characteristics of the study population. The means of total cholesterol, triglyceride, HDL-cholesterol, and fasting glucose were 200 mg/dL, 123 mg/dL, 59 mg/dL, and 95 mg/dL. These data are almost the same as the means of the total participants (201, 115, 59, 95, respectively) 6) . The means of both genders were also equivalent to the means of the total participants, indicating that this population represents all participants in this Japanese lipid survey in 2000. Although we found no difference in the mean age, total cholesterol, and HbA1c between men and women, the means of BMI, waist circumference, blood pressure, triglyceride, LDL-cholesterol, and fasting glucose were higher in men than in women, while those of HDL-cholesterol and insulin were lower in men than in women.
Results
Using the Japanese diagnostic criteria for metabolic syndrome we determined the incidence of metabolic syndrome ( Table 2 ). The incidence of metabolic syndrome in all participants was 7.8%. The incidence in men and women was 12.1, 1.7%, respectively. The incidence was about 7-fold higher in men than in women, reflecting the difference in visceral obesity defined by waist circumference, 48.2% in men and 9.7% in women. The incidence of dyslipidemia, hypertension, and glucose intolerance was also higher in men than in women in this population, indicating a higher prevalence of metabolic abnormalities in men.
It is important for us to intervene from the period of visceral obesity to prevent cardiovascular disease due to these metabolic abnormalities. Therefore, we compared the incidence of visceral obesity, visceral obesity plus one metabolic abnormality, and metabolic syndrome. Fig. 1 shows the incidence of visceral obesity, visceral obesity plus one metabolic abnormality, and metabolic syndrome. The incidence of visceral obesity plus one metabolic abnormality was about twice the incidence of metabolic syndrome both in men and women.
To compare the incidence of metabolic syndrome Dyslipidemia is defined as hypertriglyceridemia and/or low HDLcholesterolemia by Japanese and ATP criteria in this population, we determined the incidence of metabolic syndrome using these criteria in each generation from age 20s to 70s in men and women as shown in Fig. 2 . The incidence of metabolic syndrome using ATP criteria was about 3 times higher than that by the Japanese criteria. Using both criteria the incidence of metabolic syndrome started to rise in men in their 30s and reached a plateau after their 40s. Meanwhile, the incidence of metabolic syndrome in women started to rise after their 50s using both criteria, indicating the increased prevalence of metabolic syndrome after menopause.
We next examined whether visceral obesity contributed to metabolic abnormalities in this study population. Fig. 3 shows the difference of lipid profiles and fasting glucose levels with or without visceral obe- The percent incidence of metabolic syndrome, visceral obesity plus one risk factor, and visceral obesity in men and women is shown. Each column shows the mean SD of total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, and fasting glucose with or without visceral obesity in men (A) and women (B). p 0.001 sity in this study population. The levels of total cholesterol, triglyceride, LDL-cholesterol, and fasting glucose were significantly higher, while the level of HDLcholesterol was significantly lower in the group with visceral obesity than in the group without, indicating the contribution of visceral obesity to these metabolic abnormalities in both men and women. Systolic and diastolic blood pressure was also higher in the visceral obesity group in both genders (Fig. 4) . We also determined the effect of visceral obesity on the development of each abnormality by calculating the odds ratios and 95% confidence interval (Fig. 5) . Visceral obesity was significantly associated with the development of each metabolic abnormality in men and women except for low HDL-cholesterolemia in women. When we changed the cutoff of HDL-cholesterol to 50 mg/dL, visceral obesity was significantly associated with low HDL-cholesterolemia in women. The odds ratio was 2.10 and the 95% confidence interval was 1.35-3.27. Among dyslipidemia, hypertension, and glucose intolerance, visceral obesity was most associated with the development of dyslipidemia. We also determined the age-adjusted difference of lipid profile in the presence or absence of visceral obesity in this population. Even after age adjustment we found a significant difference in total cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol in men and in women, except for a difference in LDLcholesterol in women ( Table 4) .
Discussion
In this study we determined the incidence of metabolic syndrome in the Japanese general population using a lipid survey performed in 2000 using new Japanese criteria to diagnose metabolic syndrome. We found that 3 times more people were diagnosed with metabolic syndrome using the new ATP criteria than the Japanese criteria and that visceral obesity contributed to metabolic abnormalities, such as dyslipidemia, glucose intolerance, and hypertension.
In our study the incidence of metabolic syndrome in Japanese men and women was 12.1 and 1.7%, respectively. The incidence of metabolic syndrome in our survey is lower than that from the latest National Health and Nutrition survey in 2004. In that survey the incidence of metabolic syndrome in Japanese men and women was 23.0 and 8.9%, respectively. In this national survey they used HbA1c ( 5.5) instead of FBS to diagnose glucose intolerance. This might explain the difference between the two surveys. This difference also indicates that the cutoff of FBS needs to be changed in the future. Although the mean age and the criteria used were different, Takeuchi et al. Odds ratios and 95% confidence interval are shown for each abnormality in the presence or absence of visceral obesity.
reported that the incidence of metabolic syndrome in men in the Tanno and Sobetsu study was 25.3% 11) . The mean age of their study population was 60.3 years, about 15 years older than that in our study population. Other studies reported a similar incidence of metabolic syndrome in Japanese. Considering that the incidence of metabolic syndrome in our population in their 60s was about 20%, the difference of the criteria used contributed to this difference. Similar to our study Urashima et al. reported an incidence of metabolic syndrome in Japanese men and women of 14.1% and 1.7%, respectively in central Tokyo 12) . Thus, the current incidence of metabolic syndrome in Japan would be around 15% in men and a few percent in women. In our study we found that about twice as many people with metabolic syndrome had visceral obesity and one risk factor in both men and women, indicating a potential for the incidence of metabolic syndrome to increase in the future. In our previous analysis we showed that the level of triglyceride in men dramatically increased from 1990 to 2000 6) . Therefore, we need to tackle this problem to prevent the increase in metabolic syndrome and cardiovascular disease in Japan.
In this population the incidence of metabolic syndrome in women was one seventh that in men. The incidence of visceral obesity, dyslipidemia, and glucose intolerance in women was one fifth, one third, and one half that in men, respectively. Furthermore, most of the women who satisfied this criteria were more than 50 years old, which means that few women are diagnosed with metabolic syndrome before the menopause. In Japan we adopted a cutoff of waist circumference of 90 cm for women, which is 5 cm more than that for men. This might explain why the incidence of metabolic syndrome in women was much less than in men. In contrast to the cutoff waist circumference in Japan, other criteria, such as in ATP , The mean, the number of samples, and SD are shown. P value was obtained by ANCOVA.
generally have a larger cutoff in men than in women; however, our cutoff in women is based on the extensive study by Matsuzawa and his group using CT scan [13] [14] [15] . Therefore, in terms of detecting visceral obesity, 90 cm would be appropriate for Japanese women. However, we need to establish another method to select high-risk patients without visceral obesity. Our data also strongly indicate that visceral obesity using our cutoff is associated with metabolic abnormalities even after age adjustment, as shown in Fig. 5 and Table 4. Therefore, we believe that visceral obesity is a useful surrogate marker for metabolic abnormalities and intervention to reduce abdominal circumference would lead to the prevention of cardiovascular disease. However, in terms of the cutoff of HDL-cholesterol, 50 mg/dL might be better than 40 mg/dL from the odds ratio in women ( Fig. 5 and Results) as in the cutoff of the ATP criteria.
In summary we have shown that the incidence of metabolic syndrome in the Japanese general population is 7.8%, 12.1% in men and 1.7% in women. Intervention is required to prevent metabolic syndrome as well as metabolic abnormalities, such as dyslipidemia, hypertension, and glucose intolerance. The current criteria for metabolic syndrome should be assessed for the better diagnosis of women and elderly people.
